PO-1689 Potential NTCP reductions for high-risk prostate cancer patients by MR-guided adaptive radiotherapy
| Autor: | Christiansen, R.L., Dysager, L., Hansen, C.R., Schytte, T., Bertelsen, A.S., Jensen, H.R., Mahmood, F., Nyborg, C.J., Hansen, S., Agergaard, S.N., Hansen, O., Brink, C., Bernchou, U. |
|---|---|
| Zdroj: | In Radiotherapy and Oncology May 2022 170 Supplement 1:S1488-S1489 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect